BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robles-Pérez A, Luburich P, Bolivar S, Dorca J, Nolla JM, Molina-Molina M, Narváez J. A prospective study of lung disease in a cohort of early rheumatoid arthritis patients. Sci Rep 2020;10:15640. [PMID: 32973236 DOI: 10.1038/s41598-020-72768-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Bartlett EC, Renzoni EA, Sivarasan N, Desai SR. Imaging of Lung Disease Associated with Connective Tissue Disease. Semin Respir Crit Care Med 2022. [DOI: 10.1055/s-0042-1755566] [Reference Citation Analysis]
2 Narváez J, Díaz del Campo Fontecha P, Brito García N, Bonilla G, Aburto M, Castellví I, Cano-jiménez E, Mena-vázquez N, Nieto MA, Ortiz AM, Valenzuela C, Abad Hernández MÁ, Castrejón I, Correyero Plaza M, Francisco Hernández FM, Hernández Hernández MV, Rodríquez Portal JA. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatología Clínica (English Edition) 2022. [DOI: 10.1016/j.reumae.2022.03.004] [Reference Citation Analysis]
3 Rodríguez Portal JA, Brito García N, Díaz del Campo Fontecha P, Valenzuela C, Ortiz AM, Nieto MA, Mena-vázquez N, Cano-jiménez E, Castellví I, Aburto M, Bonilla G, Hernández Hernández MV, Francisco Hernández FM, Correyero Plaza M, Castrejón I, Abad Hernández MÁ, Narváez J. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis. Reumatología Clínica (English Edition) 2022. [DOI: 10.1016/j.reumae.2022.02.004] [Reference Citation Analysis]
4 Molina-Molina M, Castellví I, Valenzuela C, Ramirez J, Rodríguez Portal JA, Franquet T, Narváez J. Management of progressive pulmonary fibrosis associated with connective tissue disease. Expert Rev Respir Med 2022. [PMID: 35912842 DOI: 10.1080/17476348.2022.2107508] [Reference Citation Analysis]
5 Florescu A, Gherghina FL, Mușetescu AE, Pădureanu V, Roșu A, Florescu MM, Criveanu C, Florescu LM, Bobircă A. Novel Biomarkers, Diagnostic and Therapeutic Approach in Rheumatoid Arthritis Interstitial Lung Disease-A Narrative Review. Biomedicines 2022;10:1367. [PMID: 35740390 DOI: 10.3390/biomedicines10061367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rodríguez Portal JA, Brito García N, Díaz del Campo Fontecha P, Valenzuela C, Ortiz AM, Nieto MA, Mena-vázquez N, Cano-jiménez E, Castellví I, Aburto M, Bonilla G, Hernández Hernández MV, Hernández FMF, Correyero Plaza M, Castrejón I, Abad Hernández MÁ, Narváez J. Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 1: epidemiología, factores de riesgo y pronóstico. Reumatología Clínica 2022. [DOI: 10.1016/j.reuma.2022.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Narváez J, Díaz del Campo Fontecha P, Brito García N, Bonilla G, Aburto M, Castellví I, Cano-jiménez E, Mena-vázquez N, Nieto MA, Ortiz AM, Valenzuela C, Abad Hernández MÁ, Castrejón I, Correyero Plaza M, Francisco Hernández FM, Hernández Hernández MV, Rodríquez Portal JA. Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 2: tratamiento. Reumatología Clínica 2022. [DOI: 10.1016/j.reuma.2022.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mena-Vázquez N, García-Studer A, Rojas-Gimenez M, Romero-Barco CM, Manrique-Arija S, Mucientes A, Velloso-Feijoo ML, Godoy-Navarrete FJ, Morales-Garrido P, Redondo-Rodríguez R, Ordoñez-Cañizares MC, Ortega-Castro R, Lisbona-Montañez JM, Hidalgo Conde A, Arnedo Díez de Los Ríos R, Cabrera César E, Espildora F, Aguilar-Hurtado MC, Añón-Oñate I, Ureña-Garnica I, Fernández-Nebro A. Importance of Vaccination against SARS-CoV-2 in Patients with Interstitial Lung Disease Associated with Systemic Autoimmune Disease. J Clin Med 2022;11:2437. [PMID: 35566564 DOI: 10.3390/jcm11092437] [Reference Citation Analysis]
9 Mena-Vázquez N, Redondo-Rodríguez R, Rojas-Gimenez M, Romero-Barco CM, Manrique-Arija S, Ortega-Castro R, Hidalgo Conde A, Arnedo Díez de Los Ríos R, Cabrera César E, Espildora F, Aguilar-Hurtado MC, Añón-Oñate I, Pérez-Albaladejo L, Abarca-Costalago M, Ureña-Garnica I, Velloso-Feijoo ML, Irigoyen-Oyarzábal MV, Fernández-Nebro A. Efficacy and Safety of Rituximab in Autoimmune Disease-Associated Interstitial Lung Disease: A Prospective Cohort Study. J Clin Med 2022;11:927. [PMID: 35207203 DOI: 10.3390/jcm11040927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wu Z, Molyneaux PL. Choosing pharmacotherapy for ILD in patients with connective tissue disease. Breathe (Sheff) 2021;17:210114. [PMID: 35035571 DOI: 10.1183/20734735.0114-2021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Mena-Vázquez N, Rojas-Gimenez M, Romero-Barco CM, Manrique-Arija S, Hidalgo Conde A, Arnedo Díez de Los Ríos R, Cabrera César E, Ortega-Castro R, Espildora F, Aguilar-Hurtado MC, Añón-Oñate I, Pérez-Albaladejo L, Abarca-Costalago M, Ureña-Garnica I, Velloso-Feijoo ML, Redondo-Rodriguez R, Fernández-Nebro A. Characteristics and Predictors of Progression Interstitial Lung Disease in Rheumatoid Arthritis Compared with Other Autoimmune Disease: A Retrospective Cohort Study. Diagnostics (Basel) 2021;11:1794. [PMID: 34679492 DOI: 10.3390/diagnostics11101794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Manfredi A, Cassone G, Luppi F, Atienza-Mateo B, Cavazza A, Sverzellati N, González-Gay MA, Salvarani C, Sebastiani M. Rheumatoid arthritis related interstitial lung disease. Expert Rev Clin Immunol 2021;17:485-97. [PMID: 33779447 DOI: 10.1080/1744666X.2021.1905524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
13 Robles-pérez A, Molina-molina M, Narváez J. Tratamiento actual de la enfermedad pulmonar intersticial asociada a la artritis reumatoide. Open Respiratory Archives 2021;3:100106. [DOI: 10.1016/j.opresp.2021.100106] [Reference Citation Analysis]
14 Wells AU. New insights into the treatment of CTD-ILD. Nat Rev Rheumatol 2021;17:79-80. [PMID: 33408337 DOI: 10.1038/s41584-020-00567-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Mena-Vázquez N, Jimenez-Núñez FG, Godoy-Navarrete FJ, Manrique-Arija S, Aguilar-Hurtado MC, Romero-Barco CM, Ureña-Garnica I, Espildora F, Padin-Martín MI, Fernández-Nebro A. Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis. Clin Rheumatol 2021;40:2377-85. [PMID: 33611648 DOI: 10.1007/s10067-021-05655-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mena-Vázquez N, Rojas-Gimenez M, Romero-Barco CM, Manrique-Arija S, Francisco E, Aguilar-Hurtado MC, Añón-Oñate I, Pérez-Albaladejo L, Ortega-Castro R, Godoy-Navarrete FJ, Ureña-Garnica I, Velloso-Feijoo ML, Redondo-Rodriguez R, Jimenez-Núñez FG, Panero Lamothe B, Padin-Martín MI, Fernández-Nebro A. Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study. J Clin Med 2021;10:874. [PMID: 33672699 DOI: 10.3390/jcm10040874] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
17 Kahn N. Prädiktoren für Progression und Mortalität bei Patienten mit RA-assoziierter ILD. Kompass Pneumol 2021;9:244-247. [DOI: 10.1159/000518288] [Reference Citation Analysis]
18 Maschke J. Metastasiertes Melanom: Nach der Studie ist vor der Studie. Kompass Dermatol 2021;9:129-131. [DOI: 10.1159/000517940] [Reference Citation Analysis]
19 Kahn N. Prädiktoren für Progression und Mortalität bei Patienten mit RA-assoziierter ILD. Kompass Autoimmun 2021;3:123-125. [DOI: 10.1159/000518343] [Reference Citation Analysis]